Webinar: Accelerating RIM System Compliance with AI and Sporify
Seamlessly deploy the latest innovations and recognize immediate value.
Webinar: The Rise of Agentic PV: AI that thinks, plans, and acts
Learn how Agentic AI is bringing a new era of innovation to pharmacovigilance.
LifeSphere Safety MultiVigilance (LSSMV) database system has auto-translation capabilities that can translate safety narratives from English to Chinese and vice versa using advanced machine-learning technology.
With up to 30-50% annual growth in adverse event cases, how ...
Artificial intelligence (AI), machine learning, deep learning, natural language processing ...
The Shift to the Cloud Historically, firms relied heavily on ...
On June 9th, 2020 ArisGlobal held a webinar titled “Pharmacovigilance and ...
In the last of our three-part blog series, we share the poll results to the question "What concerns do you have when it comes to automating PV process?" and analyze the responses. Read the blog to see how your responses might compare.
In order to stay compliant with NMPA requirements (submitting all post-marketing ADRs in ICH E2B (R3) format), drug manufacturers are required to procure an electronic safety database that is.....
Pharmacovigilance is at a crossroads. The best, most innovative way forward for PV departments may well be automation, as they address the challenges (or market pull factors) and opportunities (or technology push capabilities).
Automation can have positive effects in many different areas, such as case intake, duplicate check, follow up, narrative generation, quality check or end-to-end processing. But which one are you most likely to automate?
On November 28, 2017, ArisGlobal held a webinar with DIA, “How Automation Can Deliver the Holy Grail in Safety: Achieve Productivity, Compliance and Quality”. In this webinar, we posed a few questions to the audience, and came up with some interesting information. We took this and spent some thinking about what this means to our clients in the PV ecosystem.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved